This page uses Javascript. Your browser either doesn't support Javascript or you have it turned off. To see this page as it is meant to appear please use a Javascript enabled browser.
Home
|
Latest Filings
|
Previous Page
Search the Next-Generation EDGAR System
Filing Detail
SEC Home
»
Search the Next-Generation EDGAR System
»
Company Search
»
Current Page
Form 10-12G
- Registration of securities [Section 12(g)]:
SEC
Accession
No.
0000950115-98-001863
Filing Date
1998-12-14
Accepted
1998-12-14 00:00:00
Documents
17
Document Format Files
Seq
Description
Document
Type
Size
1
GENERAL FORM FOR REGISTRATION OF SECURITIES
10-12G
275345
2
ARTICLES OF INCORPORATION
EX-3.1
34349
3
AMENDED AND RESTATED BY-LAWS
EX-3.2
24004
4
CERTIFICATE
EX-4.1
3987
5
SPECIAL VOTING RIGHTS PREFERRED STOCK
EX-4.2
9709
6
1998 STOCK OPTION PLAN
EX-4.3
27221
7
SERIES A REDEEMABLE COMMON STOCK PURCHASE WARRANT
EX-4.4.1
30576
8
WARRANT FOR THE PURCHASE OF SHARES OF COMMON STOCK
EX-4.4.2
29357
9
WARRANT
EX-4.4.3
9537
10
LETTER OF AGREEMENT
EX-4.4.4
20784
11
SUBSCRIPTION FOR SHARES OF COMMON STOCK
EX-4.5.1
13483
12
SUBSCRIPTION FOR SHARES OF COMMON STOCK
EX-4.5.2
13667
13
MEMORANDUM OF AGREEMENT
EX-10.1.1
30371
14
SUBSIDIARIES OF THE COMPANY
EX-21
793
15
CONSENT OF INDEPENDENT AUDITORS
EX-23.1.1
817
16
CONSENT OF INDEPENDENT AUDITORS
EX-23.1.2
656
17
FDS
EX-27
2334
Complete submission text file
0000950115-98-001863.txt
529859
Mailing Address
Business Address
33 HARBOUR SQ
STE 202
TORONTO ONTARIO CANA A1
GENEREX BIOTECHNOLOGY CORP (Filer)
CIK
:
0001059784 (see all company filings)
Type:
10-12G
| Act:
34
| File No.:
000-25169
| Film No.:
98768941